Basic Neuroscience & Pharmacology

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3 - Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder

Joaquim Radua, David Mataix-Cols

The British Journal of Psychiatry (2009) 195: 393-402

 

3 - Antidepressive behaviors induced by enriched environment might be modulated by glucocorticoid levels

Zhiwei Xu, Bing Hou, Youzhi Zhang, Yan Gao, Yonghong Wu, Shifu Zhao and Chenggang Zhang

European Neuropsychopharmacology. Volume 19, Issue 12, December 2009, Pages 868-875

 

3! - Genome-Wide Linkage and Follow-Up Association Study of Postpartum Mood Symptoms

Pamela Belmonte Mahon, Jennifer L. Payne, Dean F. MacKinnon, Francis M. Mondimore, Fernando S. Goes, Barbara Schweizer, Dubravka Jancic, William H. Coryell, Peter A. Holmans, Jianxin Shi, James A. Knowles, William A. Scheftner, Myrna M. Weissman, Douglas F. Levinson, J. Raymond DePaulo Jr., Peter P. Zandi, and James B. Potash

Am J Psychiatry 2009; 166:1229-1237

3 - Altered Corticostriatal Functional Connectivity in Obsessive-compulsive Disorder

Ben J. Harrison, Carles Soriano-Mas, Jesus Pujol, Hector Ortiz, Marina López-Solà, Rosa Hernández-Ribas, Joan Deus, Pino Alonso, Murat Yücel, Christos Pantelis, José M. Menchon, Narcís Cardoner

Arch Gen Psychiatry. 2009;66(11):1189-1200

 

3 - Neuropeptide S: A transmitter system in the brain regulating fear and anxiety

Hans-Christian Pape, Kay Jüngling, Thomas Seidenbecher, Jörg Lesting and Rainer K. Reinscheid

Neuropharmacology. Volume 58, Issue 1, January 2010, Pages 29-34

3 - A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection

Hulya Karatas, Yesim Aktas, Yasemin Gursoy-Ozdemir, Ebru Bodur, Muge Yemisci, Secil Caban, Atay Vural, Onur Pinarbasli, Yilmaz Capan, Eduardo Fernandez-Megia, Ramon Novoa-Carballal, Ricardo Riguera, Karine Andrieux, Patrick Couvreur, and Turgay Dalkara

The Journal of Neuroscience, November 4, 2009, 29(44):13761-13769

 

3! - Risk and resilience: Genetic and environmental influences on development of the stress response

Charles F. Gillespie, Justine Phifer, Bekh Bradley, Kerry J. Ressler

Depression and Anxiety. Volume 26 Issue 11, Pages 984 - 992

 

3! - Glucocorticoid Dysregulations and Their Clinical Correlates. From Receptors to Therapeutics

Andrea H. Marques, Marni N. Silverman, and Esther M. Sternberg

Annals of the New York Academy of Sciences 2009; Volume 1179, Pages 1 - 18

 

3 – Glucocorticoids. Mood, Memory, and Mechanisms

Owen M. Wolkowitz, Heather Burke, Elissa S. Epel, and Victor I. Reus

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 19 - 40

 

3 - Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression

Richard L. Hauger, Victoria Risbrough, Robert H. Oakley, J. Alberto Olivares-Reyes, and Frank M. Dautzenberg

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 120 - 143

 

3 - Glucocorticoid Signaling in the Cell. Expanding Clinical Implications to Complex Human Behavioral and Somatic Disorders

George P. Chrousos and Tomoshige Kino

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 153 - 166

 

3 - Glucocorticoid Receptor Polymorphisms in Major Depression. Focus on Glucocorticoid Sensitivity and Neurocognitive Functioning

Anne T. Spijker and Elisabeth F. C. van Rossum

Annals of the New York Academy of Sciences. 2009; Volume 1179, Pages 199 - 215

 

3 - Progressive brain changes in schizophrenia: a 1-year follow-up study of diffusion tensor imaging

Miho Ota, Satoko Obu, Noriko Sato, Katsuyoshi Mizukami, Takashi Asada

Acta Neuropsychiatrica. Volume 21 Issue 6, Pages 301 - 307

 

3 - White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: An activation likelihood estimation meta-analysis

Xin Di, Raymond C.K. Chan and Qi-yong Gong

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 8, 13 November 2009, Pages 1390-1394

3 - The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

Flávio Kapczinski, Vasco Videira Dias, Márcia Kauer-Sant'Anna, Elisa Brietzke, Gustavo H. Vázquez, Eduard Vieta and Michael Berk

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 8, 13 November 2009, Pages 1366-1371 

3 - The Role of DNA Methylation in the Central Nervous System and Neuropsychiatric Disorders

Jian Feng and Guoping Fan

International Review of Neurobiology. Volume 89, 2009, Pages 67-84

3! - Heritability of Structural Brain Traits: An Endophenotype Approach to Deconstruct Schizophrenia

Nil Kaymaz and J. van Os

International Review of Neurobiology. Volume 89, 2009, Pages 85-130

3 - Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis

Matthew N Hill, Ryan J McLaughlin, Anna C Morrish, Victor Viau, Stan B Floresco, Cecilia J Hillard and Boris B Gorzalka

Neuropsychopharmacology (2009) 34, 2733–2745

 

GRATIS 3 - A genetic variation of the noradrenergic system is related to differential amygdala activation during encoding of emotional memories

B. Rasch, K. Spalek, S. Buholzer, R. Luechinger, P. Boesiger, A. Papassotiropoulos and

D. J.-F. de Quervain

PNAS November 10, 2009 vol. 106 no. 45 19191-19196

 

3! - Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome)

Giles M. Tan, Danilo Arnone, Andrew M. McIntosh and Klaus P. Ebmeier

Schizophrenia Research. Volume 115, Issues 2-3, December 2009, Pages 173-181

 

3 - Specific brain structural abnormalities in first-episode schizophrenia.: A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers

Benedicto Crespo-Facorro, Roberto Roiz-Santiáñez, Rocío Pérez-Iglesias, Diana Tordesillas-Gutiérrez, Ignacio Mata, José Manuel Rodríguez-Sánchez, Enrique Marco de Lucas and José Luis Vázquez-Barquero

Schizophrenia Research. Volume 115, Issues 2-3, December 2009, Pages 191-201

 

3 - Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

Anvita Kale, Sadhana Joshi, Anilkumar Pillai, Nilesh Naphade, MSVK Raju, Henry Nasrallah and Sahebarao P. Mahadik

Schizophrenia Research. Volume 115, Issues 2-3, December 2009, Pages 209-214

 

3 - Why Sex Matters: Brain Size Independent Differences in Gray Matter Distributions between Men and Women

Eileen Luders, Christian Gaser, Katherine L. Narr, and Arthur W. Toga

The Journal of Neuroscience, November 11, 2009, 29(45):14265-14270

 

3 - Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine

Bernd Kundermann, Julia Hemmeter-Spernal, Peter Strate, Stefan Gebhardt, Martin Tobias Huber, Jürgen-Christian Krieg and Stefan Lautenbacher

Journal of Psychiatric Research. Volume 43, Issue 16, December 2009, Pages 1253-1261

 

3 - Gray and white matter brain volumes in older adults with bipolar disorder

John L. Beyer, Maragatha Kuchibhatla, Martha E. Payne, James MacFall, Frederick Cassidy, K. Ranga R. Krishnan

International Journal of Geriatric Psychiatry. Volume 24 Issue 12, Pages 1445 - 1452

 

3 - Signal Transduction via Cannabinoid Receptors

Dalton, George D; Bass, Caroline E; Van Horn, Cynthia G; Howlett, Allyn C

CNS & Neurological Disorders - Drug Targets, Volume 8, Number 6, December 2009 , pp. 422-431(10)

 

3! - Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies

Antonio Vita, Luca De Peri and Emilio Sacchetti

Bipolar Disorders. Volume 11 Issue 8, Pages 807 - 814

 

3! - Detrimental effects of glucocorticoids on neuronal migration during brain development

K Fukumoto, T Morita, T Mayanagi, D Tanokashira, T Yoshida, A Sakai and K Sobue

Molecular Psychiatry (2009) 14, 1119–1131

 

GRATIS 3 - Malfunction in GABA and Glutamate as Pathways to Depression: A Review of the Evidence

Christopher F Sharpley

Clinical Medicine: Therapeutics 2009:1 1511-1519

 

3 - microRNAs at the synapse

Gerhard Schratt

Nature Reviews Neuroscience 10, 842-849 (December 2009)

 

3 - A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder

Lisa A. Page, Katya Rubia, Quinton Deeley, Eileen Daly, Fiona Toal, David Mataix-Cols, Vincent Giampietro, Nicole Schmitz and Declan G.M. Murphy

Psychiatry Research: Neuroimaging. Volume 174, Issue 3, 30 December 2009, Pages 202-209

 

3 - Evidence of vasopressinergic-noradrenergic mechanisms in depression with above-normal plasma vasopressin concentration with and without psychotic features

Jaap G. Goekoop, Remco FP De Winter, Ron Wolterbeek, Godfried M J Van Kempen, and Victor M. Wiegant

Journal of Psychopharmacology. First published on November 26, 2009

GRATIS 3 - Genes and Language

Society for Neuroscience

Brain Briefings. November 2009

 

GRATIS 3 - Amygdala and Hippocampal Volumes in Relatives of Patients With Bipolar Disorder: A High-Risk Study

Tomas Hajek, Eva Gunde, Claire Slaney, Lukas Propper, Glenda MacQueen, Anne Duffy, Martin Alda

Can J Psychiatry. 2009;54(11):726–733

 

3 - Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimer's Disease

Rosanna Squitti, Carlo Salustri

Current Alzheimer Research. 2009; Volume 6 Issue 6: 476-487

GRATIS 3 - Anormalidades cromosómicas y esquizofrenia

Ruth Maribel Forero Castro, Carolina Cortés Duque, Mayely Paola Sánchez Espinosa, Zayda Lorena Corredor Rozo

Rev. Colomb. Psiquiat., vol. 38 / No. 3 / 2009: 534

 

GRATIS 3 - The Cellular and Molecular Substrates of Anorexia Nervosa, Part 1

John J. Medina

Psychiatric Times. November 1, 2009; Vol. 26 No. 11

 

.

Regresar a RESÚMENES NOVIEMBRE 2009